Opioid agonists and antagonists, opioid receptors
Holzgrabe, U.; Nachtsheim, C.; Siener, T.; Drosihn, S.; Brandt, W.
Die Pharmazie 52(1): 4-22
1997
ISSN/ISBN: 0031-7144 PMID: 9082464 Document Number: 483997
Document emailed within 1 workday
Related Documents
Cserpán, E.; Tryoen-Tóth, P.; Bajenaru, L.; Benyhe, S.; Maderspach, K. 1997: Differential expression of the K-2 opioid receptor protein under the effect of opioid agonists in embryonic chick neurons in vitro Neurobiology 5(2): 233-248Kotlińska, J.; Langwiński, R. 1990: The lack of effect of opioid agonists and antagonists on some acute effects of ethanol Polish Journal of Pharmacology and Pharmacy 42(2): 129-135
Romualdi, P.; Lesa, G.; Ferri, S. 1990: Chronic exposure to opioid agonists and antagonists affects prodynorphin gene expression Acta Physiologica Hungarica 75 Suppl: 247-248
Winger, G.; Skjoldager, P.; Woods, J.H. 1992: Effects of buprenorphine and other opioid agonists and antagonists on alfentanil- and cocaine-reinforced responding in rhesus monkeys Journal of Pharmacology and Experimental Therapeutics 261(1): 311-317
Marastoni, M.; Salvadori, S.; Tomatis, R.; Borea, P.A.; Bertelli, G. 1987: Opioid peptides. Biological study of [D-MetO2] dermorphin analogues in relation to the plurality of opioid receptors. Xi Il Farmaco; Edizione Scientifica 42(2): 125-131
Ray, S.B.; Gupta, Y.K.; Wadhwa, S. 2005: Expression of opioid receptor-like 1 (ORL1) and mu opioid receptors in the spinal cord of morphine tolerant mice Indian Journal of Medical Research 121(3): 194-202
Sofuoglu, M.; Portoghese, P.S.; Takemori, A.E. 1991: Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes Journal of Pharmacology and Experimental Therapeutics 257(2): 676-680
Parsons, C.G.; Herz, A. 1990: Peripheral opioid receptors mediating antinociception in inflammation. Evidence for activation by enkephalin-like opioid peptides after cold water swim stress Journal of Pharmacology and Experimental Therapeutics 255(2): 795-802
Schoffelmeer, A.N.; Yao, Y.H.; Gioannini, T.L.; Hiller, J.M.; Ofri, D.; Roques, B.P.; Simon, E.J. 1990: Cross-linking of human [125I]beta-endorphin to opioid receptors in rat striatal membranes: biochemical evidence for the existence of a mu/delta opioid receptor complex Journal of Pharmacology and Experimental Therapeutics 253(1): 419-426
Maslov, L.N.; Mrochek, A.G.; Khaliulin, I.G.; Krylatov, A.V.; Portnichenko, A.G.; Chausskaia, E.; Naryzhnaia, N.V.; Gorbunov, A.S.; Tsibulnikov, S.Iu. 2014: Perspective of use of agonists of adenosine and opioid receptors for prevention of reperfusion damages of heart. Analysis of experimental and clinical data Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 2014(5-6): 5-13
Negus, S.S.; Henriksen, S.J.; Mattox, A.; Pasternak, G.W.; Portoghese, P.S.; Takemori, A.E.; Weinger, M.B.; Koob, G.F. 1993: Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats Journal of Pharmacology and Experimental Therapeutics 265(3): 1245-1252
Rónai, A.Z.; Botyánszki, J.; Magyar, A.; Borsodi, A.; Benyhe, S.; Medzihradszky, K. 1993: Novel, delta-opioid receptor-selective peptide antagonists: demonstration of a possible opioid interaction in the absence of a protonated nitrogen and attempts to locate the protonated nitrogen site Archives Internationales de Pharmacodynamie et de Therapie 323: 114-125
Fang, L.; Knapp, R.J.; Horvath, R.; Matsunaga, T.O.; Haaseth, R.C.; Hruby, V.J.; Porreca, F.; Yamamura, H.I. 1994: Characterization of [3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: evidence for delta opioid receptor heterogeneity Journal of Pharmacology and Experimental Therapeutics 268(2): 836-846
Werling, L.L.; Brown, S.R.; Puttfarcken, P.; Cox, B.M. 1986: Sodium regulation of agonist binding at opioid receptors. II. Effects of sodium replacement on opioid binding in guinea pig cortical membranes Molecular Pharmacology 30(2): 90-95
Ferry, R.C.; Unsworth, C.D.; Molinoff, P.B. 1993: Effects of agonists, partial agonists, and antagonists on the regulation of 5-hydroxytryptamine2 receptors in P11 cells Molecular Pharmacology 43(5): 726-733
Hirning, L.D.; Peterson, L.J.; Burks, T.F. 1985: Comparison of mu opioid agonists in vitro Proceedings of the Western Pharmacology Society 28: 111-113
Lewis, J.W.; Cannon, J.T.; Stapleton, J.M.; Liebeskind, J.C. 1980: Stress activates endogenous pain-inhibitory systems: opioid and non-opioid mechanisms Proceedings of the Western Pharmacology Society 23: 85-88
Drennan, I.R.; Orkin, A.M. 2016: OPIOID CRISIS. Prehospital naloxone administration for opioid-related emergencies Jems: a Journal of Emergency Medical Services 41(3): 36-39
Krupitskiĭ, E.M. 2014: Injectable extended-release naltrexone for the prevention of relapse to opioid dependence following opioid detoxification Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(5 Pt 2): 64-72
Zimmerman, D.M.; Leander, J.D.; Reel, J.K.; Hynes, M.D. 1987: Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands Journal of Pharmacology and Experimental Therapeutics 241(2): 374-378